Bioavailability of seocalcitol. III. Administration of lipid-based formulations to minipigs in the fasted and fed state

European Journal of Pharmaceutical Sciences

Volumn 31, Issue 1, 2007, Pages 8-15

  Grove, Mette ^a,b   Müllertz, Anette ^b   Pedersen, Gitte P ^a   Nielsen, Jeanet L ^a  

^a LEO PHARMA A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Fasted state; Lipid based formulations; Oral bioavailability; Poorly soluble drug substances; Postprandial administration; Seocalcitol; SMEDDS

Indexed keywords

AKOLINE MCM; CREMOPHOR; FLUPENTIXOL DECANOATE; LIPID; MEDIUM CHAIN TRIACYLGLYCEROL; PROPYLENE GLYCOL; SEOCALCITOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG FORMULATION; FEEDING; FEMALE; FOOD; GASTROINTESTINAL TRACT; IN VIVO STUDY; MINIPIG; NONHUMAN; PRIORITY JOURNAL; SOLUBILITY;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CALCITRIOL; EXCIPIENTS; FASTING; FEMALE; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; MOLECULAR STRUCTURE; POLYETHYLENE GLYCOLS; POSTPRANDIAL PERIOD; PROPYLENE GLYCOL; SWINE; SWINE, MINIATURE; TRIGLYCERIDES;

EID: 34247137899     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2007.01.007     Document Type: Article

References (28)

1. Amidon G.L., Lennernas H., Shah V.P., and Crison J.R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12 (1995) 413-420
2. Armand M., Borel P., Pasquier B., Dubois C., Senft M., Andre M., Peyrot J., Salducci J., and Lairon D. Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum. Am. J. Physiol. 271 (1996) G172-G183
3. Aungst B.J., Nguyen N.H., Taylor N.J., and Bindra D.S. Formulation and food effects on the oral absorption of a poorly water soluble, highly permeable antiretroviral agent. J. Pharm. Sci. 91 (2002) 1390-1395
4. Charman W.N., Rogge M.C., Boddy A.W., and Berger B.M. Effect of food and a monoglyceride emulsion formulation on danazol bioavailability. J. Clin. Pharmacol. 33 (1993) 381-386
5. de Smidt P.C., Campanero M.A., and Troconiz I.F. Intestinal absorption of penclomedine from lipid vehicles in the conscious rat: contribution of emulsification versus digestibility. Int. J. Pharm. 270 (2004) 109-118
6. Dressman J.B., and Yamada K. In: Welling P.G., Tse F.L.S., and Digne S.V. (Eds). Animal Models for Oral Drug Absorption vol. 48 (2003), Marcel Dekker, New York 235-266
7. Flores C.A., Wells M.A., Morrill M., Bustamante S.A., and Koldovsky O. Diet, age and intestinal bile acids in pigs. Nutrition 8 (1992) 418-420
8. Gonzalez-Llaven J., Palma-Aguirre J.A., Garcia-Arreola R., Brizuela V., Nava-Rangel J., Moran-Lira S., Vela-Ojeda J., Castaneda-Hernandez G., and Flores-Murrieta F.J. Comparative bioavailability evaluation of two cyclosporine oral formulations in healthy Mexican volunteers. Arch. Med. Res. 30 (1999) 315-319
9. Grove M., Pedersen G.P., Nielsen J.L., and Mullertz A. Bioavailability of seocalcitol. I. Relating solubility in biorelevant media with oral bioavailability in rats-effect of medium and long chain triglycerides. J. Pharm. Sci. 94 (2005) 1830-1838
10. Grove M., Mullertz A., Nielsen J.L., and Pedersen G.P. Bioavailability of seocalcitol. II. Development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides. Eur. J. Pharm. Sci. 28 (2006) 233-242
11. Humberstone A.J., and Charman W.N. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv. Drug Deliv. Rev. 25 (1997) 103-128
12. Humberstone A.J., Porter C.J., and Charman W.N. A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine. J. Pharm. Sci. 85 (1996) 525-529
13. Kalantzi L., Goumas K., Kalioras V., Abrahamsson B., Dressman J.B., and Reppas C. Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies. Pharm. Res. 23 (2006) 165-176
14. Kararli T.T. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug Dispos. 16 (1995) 351-380
15. Khoo S.M., Shackleford D.M., Porter C.J., Edwards G.A., and Charman W.N. Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs. Pharm. Res. 20 (2003) 1460-1465
16. Matuszewska B., Hettrick L., Bondi J.V., and Storey D.E. Comparative bioavailability of L-683,453, a 5α-reductase inhibitor, from a self-emulsifying drug delivery system in Beagle dogs. Int. J. Pharm. 136 (1996) 147-154
17. Mueller E.A., Kovarik J.M., van Bree J.B., Grevel J., Lucker P.W., and Kutz K. Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a crossover comparison with the market formulation. Pharm. Res. 11 (1994) 151-155
18. Mueller E.A., Kovarik J.M., van Bree J.B., Tetzloff W., Grevel J., and Kutz K. Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation. Pharm. Res. 11 (1994) 301-304
19. Porter C.J., Kaukonen A.M., Boyd B.J., Edwards G.A., and Charman W.N. Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation. Pharm. Res. 21 (2004) 1405-1412
20. Pouton C.W. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur. J. Pharm. Sci. 11 Suppl. 2 (2000) S93-S98
21. Singh B.N. Effects of food on clinical pharmacokinetics. Clin. Pharmacokinet. 37 (1999) 213-255
22. Stuchlik M., and Zak S. Lipid-based vehicle for oral drug delivery. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 145 (2001) 17-26
23. Sunesen V.H., Vedelsdal R., Kristensen H.G., Christrup L., and Mullertz A. Effect of liquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug. Eur. J. Pharm. Sci. 24 (2005) 297-303
24. Swindle M. Comparative anatomy and physiology of the pig. Scand. J. Lab. Sci. Suppl. 25 (1998) 11-21
25. Tarr B.D., and Yalkowsky S.H. Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size. Pharm. Res. 6 (1989) 40-43
26. van Greevenbroek M.M., van Meer G., Erkelens D.W., and de Bruin T.W. Effects of saturated, mono-, and polyunsaturated fatty acids on the secretion of apo B containing lipoproteins by Caco-2 cells. Atherosclerosis 121 (1996) 139-150
27. Witkamp R.F., and Monshouwer M. Pharmacokinetics in vivo and in vitro in swine. Scand. J. Lab. Sci. Suppl. 25 (1998) 45-56
28. Wu C.Y., and Benet L.Z. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm. Res. 22 (2005) 11-23